Financials

News Discussions Technicals Seasonals

ACUC fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

AcuCort AB engages in the development, market, and sale of Dexa oral dissolvable films. Its product is primarily for acute allergic reaction, croup, and chemotherapy-induced nausea, and vomiting. The company was founded on November 15, 2006 and is headquartered in Lund, Sweden.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

ACUC does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company